Towards the personalization of septic shock resuscitation: The fundamentals of ANDROMEDA-SHOCK-2 trial

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Ramasco, F.
  • Aguilar, G.
  • Aldecoa, C.
  • Bakker, J.
  • Dominguez, D.
  • Galiana, M.
  • Hernandez, G.
  • Kattan, E.
  • Olea, C.
  • Ospina-Tascon, G.
  • Perez, A.
  • Ramos, K.
  • Ramos, S.
  • Tamayo, G.
  • Tuero, G.
  • Soc Espanola Anestesiologia
  • ANDROMEDA-SHOCK-2 Spanish

Grups d'Investigació

Abstract

Septic shock is a highly lethal and prevalent disease. Progressive circulatory dysfunction leads to tissue hypoperfusion and hypoxia, eventually evolving to multiorgan dysfunction and death. Prompt resuscitation may revert these pathogenic mechanisms, restoring oxygen delivery and organ function. High heterogeneity exists among the determinants of circulatory dysfunction in septic shock, and current algorithms provide a stepwise and standardized approach to conduct resuscitation. This review provides the pathophysiological and clinical rationale behind ANDROMEDA-SHOCK2, an ongoing multicenter randomized controlled trial that aims to compare a personalized resuscitation strategy based on clinical phenotyping and peripheral perfusion assessment, versus standard of care, in early septic shock resuscitation. (c) 2023 Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor.

Dades de la publicació

ISSN/ISSNe:
0034-9356, 2340-3284

Revista espanola de anestesiologia y reanimacion  ELSEVIER SCIENCE BV

Tipus:
Article
Pàgines:
112-124
PubMed:
38244774
Factor d'Impacte:
0,258 SCImago
Quartil:
Q3 SCImago

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • ANDROMEDA-SHOCK trial; Sepsis; Septic shock; Pulse pressure; Diastolic blood pressure; Capillary refill time; Fluid responsiveness

Compartir la publicació